Screener
Oric Pharmaceuticals, Inc. ORIC Common Stock
Common Stock at other companies
Other financials
Where this comes from
Reported directly by Oric Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockValue.
The source filing: Oric Pharmaceuticals, Inc.’s 10-Q, filed May 4, 2026.
- Filed
- May 4, 2026, 4:20 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-204047
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Commitments and contingencies | ||
| Stockholders' equity: | ||
| Preferred stock, $0.0001 par value; 200,000,000 shares authorized; no shares issued and outstanding at March 31, 2026 and December 31, 2025 | — | — |
| Common stock, $0.0001 par value; 1,000,000,000 shares authorized; 103,486,412 and 98,528,949 shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively | 11 | 11 |
| Additional paid-in capital | 1,143,845 | 1,075,807 |
| Accumulated deficit | (728,009) | (692,242) |
| Accumulated other comprehensive (loss) income | (290) | 786 |
| Total stockholders' equity | 415,557 | 384,362 |
Item 1. Financial Statements.
FAQ
- What is Oric Pharmaceuticals, Inc.'s common stock?
- Oric Pharmaceuticals, Inc. (ORIC) reported common stock of $11K in Q1 2026.
- How has Oric Pharmaceuticals, Inc.'s common stock changed year-over-year?
- Oric Pharmaceuticals, Inc.'s common stock increased by 57.1% year-over-year, from $7K to $11K.
- What is the long-term trend for Oric Pharmaceuticals, Inc.'s common stock?
- Over 5 years (2020 to 2025), Oric Pharmaceuticals, Inc.'s common stock has grown at a 22.4% compound annual growth rate (CAGR), from $4K to $11K.
- What does common stock mean?
- The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).
Ask your AI about Oric Pharmaceuticals, Inc.'s common stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude